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Abstract
There is growing concern that coronary heart
disease (CHD) is becoming more common and that
hypercholesterolaemia may be an important problem
among Hong Kong Chinese. This study aims at
finding out the prevalence of hypercholesterolaemia
among adult patients in general practice. 1113
Chinese patients aged 21 to 60 attending a
Government general outpatient clinic were randomly
sampled. The demographic data and information on
other CHD risk factors were obtained from each
participant. All participants had their cholesterol
measured by the Reflotron. The reflotron cholesterol
results were validated and calibrated against
laboratory results. The survey showed 10% of the
sample had blood cholesterol > 6.2mmol/l, and
32% had borderline hypercholesterolaemia between
5.2 to 6.2mmol/l. Less than 1% of the people had
cholesterol levels above 7.8mmol/l. Age had the
most significant effect on cholesterol level especially
in females after 40. One in four females over 50
had blood cholesterol levels > 6.2mmol/l. Twenty-
one percent of the sample had > 2 other CHD risk
factors, over half of them had cholesterol
>5.2mmol/l. The main problem among Hong Kong
Chinese is borderline hypercholesterolaemia which is
most significant in people with additional CHD risk
factors. Cholesterol screening will be more cost-
effective if directed to people known to have other
CHD risk factors but may not be worthwhile for the
low risk group.
Keywords: Cholesterol, Chinese, screening,
prevalence
Introduction
There is growing concern that coronary heart
disease (CHD) is becoming more common in the
Chinese populations as they live longer and
become more affluent.1"4 For example, the total
CHD deaths per 100,000 population nearly
doubled from 28.4 in 1972 to 54.7 in 1992 in Hong
Kong as a result of the aging of the population.4
The age standardized coronary mortality rates in
Hong Kong has remained the same in the last two
decades in contrast to big declines in many
Western countries.1'4 The decline in CHD
mortality in the U.S.A. has been attributed to the
active national cholesterol campaign.5 Some
studies showed that hypercholesterolaemia was an
important CHD risk factor in the Chinese,6'7 as in
the Westerners.8"13 Should we be more active in
the screening and treatment of hypercho-
esterolaemia in our population? Two previous
local studies on adults aged 18 to 64 years old
*Address for correspondence: Dr. Cindy L.K. Lam, General Practice Unit, 3rd floor, Ap Lei Chau Clinic, 161 Main Street, Ap Lei Chau,
Hong Kong.
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showed that prevalences of hypercholesterolaemia
> 6.2mmol/l were as high as 16%14 and 20%.15
These studies were carried out on very specific
population groups whose results might not be
applicable to general practice where most of the
screening and treatments take place.
Is hypercholesterolaemia common among
Chinese patients in general practice in Hong
Kong? Our study aims at finding out the answer.
We also hope to identify the high risk groups to
whom services can be targeted. The information
will help general practitioners rationalize their
approach to screening and management of
hypercholesterolaemia.
Method
The study was carried out from June 15 to
September 15, 1990 at a four-doctor Government
general outpatient clinic in Wanchai, Hong Kong.
Two trained interviewers sampled the subjects
from patients consulting two of the four doctors
each day. The doctors were selected in rotation
each day so that their patients would have equal
chance to be sampled during the study period.
Every one in four patients of the selected
doctors were approached by two trained
interviewers before their doctor consultations.
Chinese patients aged 21-60 were invited to take
part in the study. The next patient was invited if
the initial sampled subject was outside the age
limit, had been sampled before, or if he/she
refused to participate.
The interviewers administered a structured
questionnaire to each participant on demographic
data and coronary heart disease (CHD) risk
factors. The major CHD risk factors included
male, family history of premature (before the age
of 55) coronary heart death or sudden death,
current smoking of > 10 cigarettes per day,
hypertension on treatment or blood pressure >
160/90, known diabetes mellitus, history of definite
stroke or occlusive peripheral vascular disease,
and BMI > 30.16
Each subject was then seen by the second
author (M.G.C.) for measurements of weight,
height, blood pressure, and serum cholesterol after
the interview. Serum blood cholesterol was
measured by the Reflotron (Boerhinger
Mannheim, W. Germany, 1988), a desk-top
analyzer, on a drop of capillary blood obtained by
a finger prick. All the cholesterol tests were
performed by the second author (M.G.C.) who
had received a training session from the supplier
of the machine before the study. The testing
procedures listed in the Operation Manual were
closely followed. The Reflotron was calibrated
every morning before the tests with check strips
from the supplier. Quality checks by standard
sera from the supplier were performed once a
week.
Validation and calibration of the Reflotron
cholesterol results were done on 125 subjects who
also had blood cholesterol tested by the
laboratory. The details of the validation study was
presented in another paper.17 The validation study
showed that blood cholesterol (BC) level could be
calculated from the reflotron cholesterol (RC)
level by the regression equation: BC = 0.8395 -t-
0.8995 x RC.17 The three threshold levels of RC
that corresponded to the three commonly used
blood cholesterol thresholds of 5.2, 6.2 and
1.8mmol/ln were 4.8, 6.0 and l.lmmolfl,
respectively.
All the data were analyzed using the SPSS-
PC+ (Statistical Packages for Social Science —
Personal Computer) programme18 and the SAS
(Statistical Analysis Software).19
Results
Sample
There were 1616 (56% females, 44%
males) eligible patients approached, 1113 (69%)
404
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completed the questionnaire and Reflotron
cholesterol screening. These 1113 subjects
made up the total sample for further analysis.
There were 622 (56%) females and 491 (44%)
males. The mean age of the sample was 38.7
years (S.D. 11.2). The distributions of the
social class by occupation,20 drinking status,
daily physical activity levels and frequency of
sweating exercises are shown in Table 1.
Table 1: Characteristics of the Study Sample
Proportion (N = 1113)
Social Class
I
II
III
IV
V
Daily Activity
Light
Moderate
Heavy
Drinking Status
Current Drinker
Ex-Drinker
Non Drinker
Sweating Exercises
>3*/week
l-3iir/week
< to/week
1%
11%
61%
17%
10%
49%
41%
10%
14%
2%
84%
18%
28%
54%
One percent of the sample were known to
have CHD. The number of known major CHD
risk factors ranged from O to 5 and 21% had
two or more. Nine percent were current
smokers and 3% were ex-smokers. The sample
were known to have hypertension in 14%,
diabetes mellitus in 4%, hyperlipidaemia in 2%,
previous strokes in 1% and other atherosclerotic
diseases in 0.4%. Five percent of the subjects
had a positive family history of premature CHD
or sudden death in one or more parent or
sibling. Five percent of the subjects had a BMI
30 or above. Seventy-one percent of people
were aware of the association between
hypercholesterolaemia and CHD, and 9% ever
had their blood cholesterol checked before.
Prevalence of Hypercholesterolaemia
The Reflotron cholesterol (RC) levels of
the 1113 subjects ranged from 2.6 to 10.8mmol/l
and the mean was 4.8 (S.D. 0.99) mmol/l.
Four hundred and seventy (42%) of the
subjects had blood cholesterol above the
desirable level of 5.2 (RC 4.8) mmol/l. Thirty-
two percent had borderline hypercho-
lesterolaemia between 5.2 to 6.2mmol/l,
10% had blood cholesterol levels > 6.2
(RC > 6.0) mmol/l, and only 0.7% had levels
> 7.8 (RC > 7.7) mmol/l.
Table 2 shows the prevalence of
hypercholesterolaemia by the number of CHD
risk factors. Over half of those with S 2 CHD
risk factors had blood cholesterol levels > 5.2
(RC > 4.8) mmol/l) and 16% had levels > 6.2
(RC >6.2) mmol/l. Only 8% of the low risk
group had blood cholesterol > 6.2nimol/l.
Table 2: Prevalence of Hypercholesterolaemia
by CHD Risk
No. of CHD Risk Factors
< 2 (N=882) 2 (N=231)
Blood Cholesterol*
(mmol/l)
Mean
>5.2 & < 6.2
>6.2
5.06
32%
8%
5.37
37%
16%
Blood Cholesterol
= 0.8395 + 0.8995 x Reflotron Cholesterol
Effects of Patient Characteristics on
Cholesterol
Pearson correlation analysis was done
between cholesterol level and age, body mass
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index, systolic blood pressure and diastolic blood
pressure, and ANOVA (Analysis of Variance)
was used to test the effects of sex, social class
by occupation (I to V), daily level of physical
activity (l=light, 2=moderate, 3 = heavy),
smoking status (1=current smoker, 2=ex-smoker,
3=non-smoker), drinking status (1=current
drinker, 2=ex-drinker, 3 = non-drinker), frequency
of sweating exercise (l = >3x/wk, 2=l-3#/wk,
3 = <lx/wk) on the cholesterol level.
Table 3 shows those factors that have
significant effects on the cholesterol level.
Cholesterol levels increased with increasing age,
systolic blood pressure, diastolic blood pressure,
body mass index (BMI). It increased with social
class from I to V which meant people from the
lower social class tended to have higher
cholesterol than those from the middle class
(Table 4). There was no trend in the
correlations between the cholesterol level and
daily physical activity, frequency of sweating
exercise or drinking. There was no significant
correlation between cholesterol level and sex or
smoking status. The correlations between
cholesterol level and any of the factors except
age were very weak although they were
statistically significant because of the large
sample size.
Table 4: Blood Cholesterol Levels by Social Class
Blood Cholesterol*
Mean >5.2 > 6.2
(mmol/t)
>7.8
Social Class
I (N=9)
II (N=124)
III (N=681)
IV (N=191)
V (N=108)
4.6
5.1
5.1
5.2
5.4
22
39
42
41
54
0
n
9
7
18
0
0
1
1
1
* Blood Cholesterol = 0.8395 + 0.8995 x Reflotron Cholesterol
The distribution of cholesterol levels by age
and sex of the sample is shown in Table 5.
Overall 10% of the females and 9% of the males
had blood cholesterol levels > 6.2mmol/l. The
mean cholesterol level and prevalence of
hypercholesterolaemia increased with age in both
sexes. Blood cholesterol levels over 6.2mmol/l
(RC > 6.0mmol/l) were uncommon before the age
of 40 but were found in 25% of the females and
18% of the males aged 51-60.
Table 5: Blood Cholesterol Levels by Age & Sex
of the Sample
Blood Cholesterol* (mmol/l)
Mean >5.2 >6.2 >7.8
Age & Sex
iii Die j. Y mumies
Effect on
mat nuu a
Cholesterol
Variable Correlation Coefficient
Pearsou Correlation
Age
Systolic B.P.
Diastolic B.P.
B.M.I.
ANOVA
Physical Activity
Sweating Exercise
Social Class
Drinking
0.37
0.29
0.25
0.22
0.015
0.014
0.014
0.008
Significant
P Value
< 0.0001
< 0.0001
< 0.0001
<0.0001
<0.0001
< 0.0001
0.003
0.01
21-30 yrs
M (N=112)
F (N=213)
T (N=325)
31-40 yrs
M (N = 183)
F (N=163)
T (N=346)
41-50 yrs
M (N =87)
F (N=116)
T (N =203)
51-60 yrs
M (N = 108)
F (N=130)
T (N =238)
* Blood Cholesterol
4.7
4.8
4.8
5.1
5.0
5.0
5.2
5.3
5.2
5.5
5.8
5.7
= 0.8395
19
24
22
43
36
40
40
52
47
63
74
69
+ 0,8995
5
2
2
8
6
7
8
16
12
18
25
21
x Reflotron
0
0.5
0.3
0.5
1
0.9
0
1
0.5
0
2
1
Cholesterol
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Discussion
We had over 1000 subjects in our sample
with a wide spread of age, and social
background. The Government outpatient clinic
in our study was in a very central location and
was attended by patients from all areas in the
territory. We believe that our results could be
applied to other general practice populations in
Hong Kong. We used the Reflotron for
cholesterol testing in our study in order to
improve the response rate to the study.17 The
response rate in an earlier study using blood test
for cholesterol measurement was only 30%.21
There is no absolute 'normal' level of
cholesterol. The relation between cholesterol
and CHD has been found to be curvilinear.10"12
The incidence of CHD starts to increase above
the level of 5.2mmol/l, it increases more sharply
above 6.2mmol/l and very sharply above
7.8mmol/l.n Most guidelines use 6.2mmol/l as
the threshold for hypercholesterolaemia, and
5.2mmol/l as the threshold for desirable levels.22'23
Ten percent of our population had
hypercho-lesterolaemia of >6.2mmol/l; the
prevalence was lower than those found by Lau et
a/14 and Fong el a/.15 The age-standardized
mean cholesterol level of the Hong Kong adult
population aged 21 to 60,26 estimated from our
results, is 5.lmmol/l. This is lower than the
5.5mmol/l estimated by Fong et a/.15 The
patients in the study by Fong et al were self-
referred and many (7.9%) had CHD. It is not
surprising that they had higher cholesterol levels
than our unselected patients in general practice.
Lau et al sampled their subjects from a public
utility company and a hospital with variable
response rates from 50% to 73% which might
have biased the results. Our results showed that
our population had lower mean cholesterol level
and prevalence of hypercholesterolaemia over
6.2mmol/l than most Western countries.10"13'27
They were lower than those of the Chinese in
Singapore28 but higher than those in China,29
which coincided with the relative coronary
mortality rates.1-4
Nearly half of our patients had blood
cholesterol levels above the desirable level of
5.2mmol/l. The majority of these undesirable
cholesterol levels were between 5.2mmol/l and
6.2 mmol/l (Reflotron cholesterol 4.8-6.0mmolfl).
This borderline hypercholesterolaemia is
significant for those with additional CHD risk
factors but is of doubtful significance among the
low risk group.22"25'30'31
Very few people (9%) ever had their
cholesterol levels checked before our study.
Many known to have other CHD risk factors like
smoking, family history of premature CHD death
or hypertension had never been screened for
hypercholesterolaemia. There seems to be a
need for more cholesterol screening among
patients with additional CHD risk factors.
Very few people (< 1%) had cholesterol
levels >7.8mmol/l. The benefit from lipid
lowering drugs for cholesterol levels below
7.8mmol/l is doubtful.25'26'31 The mainstay of
treatment for hypercholesterolaemia in our
population, if any is needed, is diet. Our limited
resources may be better directed to the
development and evaluation of community and
individual dietary intervention programmes than
lipid lowering drugs.
The prevalence of hypercholesterolaemia
increased with age with a sharp rise after the age
of 40 for females and after the age of 50 for the
males. This increase was particularly marked in
females after 40 which agreed with the
finding of other studies.14'15'25'32 It is believed
that menopause has an adverse effect on lipid
metabolism.22'32 As many as one in four women
aged 51-60 had Cholesterol levels > 6.2mmiol/l.
Some people believe that this is the reason for
the rapid increase in CHD mortality rates in
women after menopause.4 However, because
most of the studies on cholesterol have been
409
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done on men, we are still not sure of the
significance of hypercholesterolaemia in females
and whether intervention makes any difference.33
We did not find the same social class effect
on cholesterol level as an earlier study in
Shatin.34 Our results actually showed quite the
opposite trend and so did our earlier study.22
This may be due to differences in the methods of
sampling and social classification. It must be
stressed that the social class effect on cholesterol
in our study was weak. The main difference was
found in those from social class one whose
sample size was very small. Further studies are
required before we can conclude if social class
has a significant effect on cholesterol levels.
Conclusion
The main problem that Hong Kong Chinese
have is borderline hypercholesterolaemia between
5.2 and 6.2mmol/l. This has implications for
both screening and intervention programmes.
Screening is most cost-effective for people with
s 2 CHD risk factors more than half of whom
may have cholesterol levels that could double
their CHD risk.30 On the other hand, it may be
a waste of resources to screen those without
CHD or any additional CHD risk factor.
One fifth of the Chinese patients presenting
to our general practice had 2 or more CHD risk
factors. There is great potential for opportunistic
screening for hypercholesterolaemia in general
practice. Although there is still a lot of debate
on the cost-effectiveness of treating
hypercholesterolaemia, information on the
cholesterol level may influence the management
of other CHD risk factors like hypertension,
diabetes, smoking, and obesity.
We now know that borderline hypercho-
lesterolaemia is common among Hong Kong
Chinese but we do not really know its
significance or the effect of intervention on our
population. Most of the research data related to
hypercholesterolaemia have come from Western
populations with higher mean cholesterol levels.
Can these results be generalized to our
population? More research is required to answer
these questions.
Acknowledgement
This study was funded by grants from the
Committee on Research and Conference Grant
and the Medical Faculty Sun Yat Sen
Foundation Research Fund of the University of
Hong Kong. We would like to thank Mr. Nam
Tat for his assistance in data analysis. Thanks
also go to Merck Sharp & Dohme (Asia) Ltd.
for sponsoring the reagent strips. •
References
1. Rosser W.W., Palmer W.H, Fowler G, el al. An international perspective
on the cholesterol debate. Family Practice 1993; 10: 431-438.
2. Hughes K. Trends in mortality from ischaemic heart disease in Singapore,
1959 to 1983. Int J epiderm 1986; 15: 44-50.
3. Cheng T.O. Changing prevalence of heart diseases in People's Republic
of China. Annals of Internal Medicine 1974; 80: 108-109.
4. Department of Health. Coronary heart disease and lung cancer. Public
Health Report no. 1. Hong Kong: Government Printer 1994; pp. 14-32.
5. Johnson C.L, Rifkind B.M., Sempos C.T., el al. Declining serum total
cholesterol levels among US adults. JAMA 1993; 269: 3002-3008.
6. Chen Z., Peto R., Collins R, MacMahon S., Lu J., Li W. Serum
cholesterol concentration and coronary heart disease in population with
low cholesterol concentrations. Br Med J 1991; 303: 276-282.
7. Schwartzkopff W, Schleicher J, Pottins I, Yu S.B., Han C.Z., Du D.Y.
Lipids, lipoproteins, apolipoproteins, and other risk factors in Chinese men
and women with and without myocardial infarction. Atherosclerosis 199O;
82: 253-259.
8. Grundy S.M. Cholesterol and coronary heart disease - future directions.
JAMA 1990; 264: 3053-3059.
9. Keys A. Coronary heart disease in seven countries. Circulation 1970; 41
(suppl.): 186-195.
10. Anderson KM., Castelli WP., Levy D. Cholesterol and Mortality- 3O
years of follow-up from the Framingham Study. JAMA 1987; 257: 2176-
2180.
11. Stamler J., Wentworth D., Neaton J.D. Is relationship between serum
cholesterol and risk of premature death from coronary heart disease
continuous and graded? JAMA 1986; 256: 2823-2828.
12. Pooling Project Research Group. Relationship of blood pressure, serum
cholesterol, smoking habit, relative weight and ECG abnormalities to
incidence of major coronary events: final report of the Pooling Project.
J Chron Dis 1978; 31: 201-306.
13. Lipid Research Clinics Programme. The lipid Research Clinics Coronary
Prevention Trial results, I: Reduction in incidence of coronary heart
disease. JAMA 1984; 251: 351-364.
14. Lau E, Woo J. Cockram C.S, el al. Serum Lipid Profile and Its
Association with Some Cardiovascular Risk Factors in an Urban Chinese
Population. Pathology 1993; 25: 344-350.
410
Hong Kong Practitioner 17 (9) September 1995
15. Fong P.C, Tam C.F, Epidemiologic studies of the serum lipids and
apolipoproteins in Hong Kong Chinese: demographic characteristics and
serum lipid and apolipoprotein distributions. I. Epidemiol Comm Med
1994; 48: 355-359.
16. Naito H.K. New guidelines and recommendations on the detection,
evaluation, and treatment of patients with undesirable cholesterol levels.
Am J Clin Pathol 1988; 90: 358-361.
17. Lam C.L.K, Catarivas M.G, Lauder I.J. Is a desk top analyzer the answer
to cholesterol screening? The H.K. Practitioner 1995; (in press)
18. Norusis MJ. SPSS/PC+ for the IBM PC/XT/AT. Chicago: SPSS Inc,
1986.
19. SAS Institute Inc, SAS User's Guide, Vol. 1 & 2; North Carolina 1988.
20. General Registrar Office. Register General's classification of occupation.
HMSO, London, 1966.
21. Lam C.L.K, Munro C, Siu B.P.C. Detection of asymptomatic
hypercholesterolaemia in middle-aged Chinese in general practice in Hong
Kong. H.K. Pract. 1990; 12: 715-730.
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults. Summary of the second report of the National
Cholesterol Education Programme (NCEP) Expert Panel on detection,
evaluation, and treatment of high blood cholesterol in adults. JAMA 1993;
269: 3015-23.
23. European Atherosclerosis Society. The recognition and management of
hyperlipidaemia in adults: a policy statement of the European
Atherosclerosis Society. Eur Heart J 1988; 9: 571-600.
24. British Hyperlipidaemia Association. Detection and management of blood
lipid disorders. London: Current Science Ltd. 1990; pp. 3-14.
25. Toronto Working Group on Cholesterol Policy. Detection and
management of asymptomatic hypercholesterolaemia. Toronto: Ontario
Ministry of Health and Ontario Medical Association, 1989; pp. 69-74.
26. Lee S.H. Department of Health Annual Report 1992/93. Hong Kong:
Hong Kong Government 1993; p. 37.
27. Keil U, Kuulasmaa K, WHO MONICA Project: risk factors. Int J
Epiderm 1989; 18 (Suppl 1): S46-S55.
28. Hughes K, Yeo P.P.B, Lun K.C, el al. Ischaemic heart disease and its
risk factors in Singapore in comparison with other countries. Annals
Academy of Medicine 1989; 18: 245-249.
29. Yang X.S, Kesteloot H, Huang D.X. Serum cholesterol in China and the
West. Chinese Med J 1986; 99: 183-186.
30. Malenka DJ, Baron J.A. Cholesterol and coronary heart disease - the
importance of patient-specific attributable risk. Arch Intern Med 1988;
148: 2247-2252.
31. Smith GD, Song F, Sheldon T.A. Cholesterol lowering and mortality:
the importance of considering level of risk. Br Med J 1993; 306: 1367-
1373.
32. Matthews KA, Meilahn E., Kuller L.H, Kelsey S.F., Caggiula AAV, Wing
R.R. Menopause and risk factors for coronary heart disease. N Engl S
Med 1989; 321: 641*46.
33. Hulley S.B., Walsh J.M., Newman T.B. Health policy on Wood
cholesterol: time to change directions. Circulation 1992; 86: 1026-1029.
34. To C Y, Donnan S.P.B. Health risks, 6tness and quality of life in adults
in Hong Kong. Hong Kong: Chinese University of Hong Kong 1988; pp.
48-49.
411
